Ignite Creation Date:
2024-05-06 @ 3:21 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02270788
Status:
COMPLETED
Last Update Posted:
2017-10-03
First Post:
2014-10-17
Brief Title:
Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Organization Data
Organization:
St Jude Childrens Research Hospital
Class:
OTHER
Study ID:
RELHEM2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
St Jude Childrens Research Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ohio State University | OTHER |
| Arog Pharmaceuticals Inc | INDUSTRY |